3
Announcements
Trials
Browse
Landscape
Status
Completed
1
Sponsor Class
INDUSTRY
1
Study Type
Observational
1
Sponsor
Cancer Type
Gynecologic
2
Thoracic
1
Sarcoma
1
Plasma cell
1
Other solid neoplasm
1
Other hematologic neoplasm
1
NET
1
Myeloid
1
Lymphoid
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
Endocrine
1
Dermatologic
1
CNS
1
Breast
1
Conditions
Head and Neck Neoplasms
34
Squamous Cell Carcinoma of Head and Neck
32
Nasopharyngeal Carcinoma
22
Mouth Neoplasms
10
Oropharyngeal Neoplasms
8
Carcinoma, Squamous Cell
8
Laryngeal Neoplasms
7
Neoplasms
6
Melanoma
5
Lung Neoplasms
5
Colorectal Neoplasms
5
Pharyngeal Neoplasms
4
Pancreatic Neoplasms
4
Ovarian Neoplasms
4
Kidney Neoplasms
4
Breast Neoplasms
4
Stomach Neoplasms
3
Neoplasm Metastasis
3
Uterine Cervical Neoplasms
2
Tongue Neoplasms
2
Thyroid Neoplasms
2
Skin Neoplasms
2
Recurrence
2
Paranasal Sinus Neoplasms
2
Nasopharyngeal Neoplasms
2
Lymphoma, Non-Hodgkin
2
Liver Neoplasms
2
Laryngeal Diseases
2
Hypopharyngeal Neoplasms
2
Glioblastoma
2
Interventions
pembrolizumab
2
Magnetic Resonance Spectroscopy
2
Immunoglobulin G
2
ulixertinib
1
trastuzumab biosimilar HLX02
1
trametinib
1
seribantumab
1
sapanisertib
1
relatlimab
1
pertuzumab
1
palbociclib
1
osimertinib
1
omipalisib
1
larotrectinib
1
ipatasertib
1
erdafitinib
1
defactinib
1
dabrafenib
1
copanlisib
1
cemiplimab
1
capivasertib
1
binimetinib
1
adavosertib
1
X-Rays
1
Trastuzumab
1
Sunitinib
1
Specimen Handling
1
Robotic Surgical Procedures
1
Radionuclide Imaging
1
Quality of Life
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uterine Neoplasms
×
Drug Therapy
×
Head & Neck
×
Clear all
NCT04028479
2024-12-18
ROOT
Taproot Health
Completed
167 enrolled